Alzheimer's Disease Research Foundation
Alzheimer's Disease Research Foundation, operating as Cure Alzheimer's Fund (CureAlz), is a 501(c)(3) nonprofit organization headquartered in Wellesley Hills, Massachusetts. Established in 2004, the organization is dedicated to funding research with the highest probability of slowing, stopping, or reversing Alzheimer's disease. The foundation has distributed over $200 million in research grants since its inception and maintains a 36-person staff.
Financial Overview
From 2024 IRS Form 990-PF · View filing
Total Assets
$28.6M
-14.6% YoY
Annual Giving
$24.4M
+5.6% YoY
Grant Count
106
+8.2% YoY
Avg Grant Size
$230K
-2.4% YoY
Mission & Focus Areas
Mission: To fund research with the highest probability of slowing, stopping, or reversing Alzheimer's disease.
Primary Research Areas:
- Alzheimer's Genome Project™
- Genes to Therapy / Stem Cell Screening
- Identification of disease mechanisms
- Immune System Structures & Processes
- Interaction of the Microbiome
- Pathological Pathways & Systems
The organization supports research across multiple disease understanding domains, including investigations into genetic factors, the role of the gut microbiome and immune system in brain health, and novel prevention and treatment approaches.
Grantmaking
Ready to take the next step with Alzheimer's Disease Research Foundation?
Geographic Focus
Where this funder awards grants
The foundation funds research internationally, with active grantmaking in:
- United States
- United Kingdom
- Germany
- Israel
Grant Distribution by State
States
Cities
Financial History
Multi-year comparison from IRS filings
As of 2023 Tax Filing:
- Total Assets: $33,488,279
- Total Revenue: $37,725,207
- Total Giving/Expenses: $34,633,548
- Total Liabilities: $1,730,000
Historical Milestones:
- 2021: Surpassed $125 million in cumulative research funding
- 2022: Raised $32 million in contributions (14% increase from 2021), received support from nearly 24,000 donors
| Metric | 2024 | 2023 | 2022 |
|---|---|---|---|
| Total Assets | $28,586,231 | $33,488,279 | $30,192,784 |
| Revenue | $31,755,677 | $37,725,207 | $40,708,245 |
| Expenses | $36,999,068 | $34,633,548 | $30,613,014 |
| Qualifying Distributions | — | — | — |
| Net Investment Income | $964,653 | $1,042,285 | $8,359,727 |
| Distributable Amount | — | — | — |
Giving Over Time
Total grant dollars and number of grants per year
Grant Insights
How this funder distributes its grants
Top Recipients
Top 10 recipients in 2024
Grant Size Distribution
247 grants across all recorded years
Giving History
Grant recipients and amounts by year
No grants recorded for .
Leadership & Key People
Leadership team and compensation from IRS filings
Chief Executive Officer: Tim Armour (as of 2023)
Chief Executive Officer: Margaret Smith (as of October 2023)
Compensation Overview
From 2024 IRS filing
From 2024 filing
| Name | Title | Hours | Compensation |
|---|---|---|---|
| MARGARET E SMITH | CEO | 40 | $426,320 |
| HENRY MCCANCE | CHAIR | 5 | — |
| PHYLLIS RAPPAPORT | TREASURER | 5 | — |
| TIMOTHY ARMOUR | DIRECTOR | 3 | — |
| RICHARD BIRNBAUM | DIRECTOR | 4 | — |
| MARK FAGGIANO | DIRECTOR (FROM 10/24) | 3 | — |
| MARY GREENHILL CAGLIERO | DIRECTOR (FROM 10/24) | 3 | — |
| ROBERT GREENHILL | DIRECTOR (TO 10/24) | 3 | — |
| KUMAR MAHADEVA | DIRECTOR (FROM 12/24) | 3 | — |
| JACQUELINE MORBY | DIRECTOR | 4 | — |
| JOSEPHINE ANTONELLIS | CFO | 30 | $200,226 |
| LAUREL LYLE | SECRETARY & VP BOARD RELATIONS & DEV OPS | 30 | $121,094 |
| KATHARINE HERMAN | EVP DEVELOPMENT | 40 | $418,581 |
| JULIE HARRIS | EVP RESEARCH MGMT (TO 12/24) | 40 | $296,359 |
| BARBARA CHAMBERS | EVP MARKETING & COMM. | 40 | $267,548 |
| LISA RAND | VP MARKETING & COMM. | 40 | $199,320 |
| DANIEL HARPER | VP DEVELOPMENT | 40 | $195,493 |
| JOHN SLATTERY | SVP, PHILANTHROPIC PARTNERSHIPS | 40 | $198,792 |
| MAHUA DASGUPTA | SR. PHILANTROPIC ADVISOR | 40 | $178,255 |
| THIDAPHORN SENGSAVANH | DIRECTOR OF DEVELOPMENT OPS | 40 | $154,055 |
Recent News & Activity
Recent developments and announcements
**2023:** Cure Alzheimer's Fund announced its 18th consecutive year of record results, with 2022 marking the strongest year in organizational history.
**Recent Achievements:**
Awarded the 1,000th research grant
CURE ALZHEIMER'S FUND AWARDS 1,000TH RESEARCH GRANTReceived a $50 million gift to support research
Cure Alzheimer's Fund Receives $50 Million Gift to Support ...Launched the Brain Aging Consortium to decode how aging shapes Alzheimer's risk
CURE ALZHEIMER'S FUND LAUNCHES BRAIN AGING ...**Recognition:**
Maintains a 100% perfect score and Four-Star rating from Charity Navigator for more than 13 consecutive years
Received a Platinum Seal of Transparency
**Notable Research Outcomes:**
The Alzheimer's Genome Project, funded through grants, has revealed four novel sex-specific Alzheimer's disease genes that confer opposite risk impact in men versus women, with variations in three genes increasing AD risk in men while appearing protective in women
CURE ALZHEIMER'S FUND AWARDS 1000TH ...Subject Areas
Focus areas based on grantmaking activity
Data last updated April 2026. Sourced from IRS Form 990-PF filings. Research dossier generated April 2026.
What could you do with Alzheimer's Disease Research Foundation on Grantable?
- Assess strategic fit with your organization
- Draft a tailored letter of inquiry
- Find open RFPs from this funder
- Monitor for new funding opportunities